Sign up now

Outstanding contribution Award -Dave Tudor

From left to right: Mr Alex Neil, MSP; Dave Tudor, winner of the Outstanding Contribution Award and Julia Brown, Director of Life & Chemical Sciences

News

Outstanding contribution Award -Dave Tudor

05 Mar, 2014

Published over 12 years ago. See the latest and most current information on News.

Scottish Lifesciences Association

1 min read

Request information

Dave Tudor is the vice president of global primary manufacture for GSK, with responsibility over 9 manufacturing sites including two in Scotland. He is the leader of GSK’s Steering Group for Scotland, supporting the substantial investments made at the Irvine and Montrose facilities. He is responsible, on behalf of the Life Sciences Advisory Board, for driving the development of a life and chemical sciences manufacturing strategy.

Latest News

Gut bacterial molecule may be biomarker of rare disease of liver and bile duct

Research news

Gut bacterial molecule may be biomarker of rare...

Researchers have identified imidazole propionate, a metabolite produced by gut bacteria, as a pos...

Helicobacter pylori may be linked to more than 20 per cent of bowel cancer cases

Research news

Helicobacter pylori may be linked to more than...

Exploratory analysis finds link between H. pylori exposure and bowel cancer risk, with those born...

Dormant chickenpox virus is an under-recognised cause of serious disease

Research news

Dormant chickenpox virus is an under-recognised...

Varicella zoster virus, the cause of chickenpox and shingles, can trigger stroke, vision loss and...

Severe type 2 asthma linked to subtle changes of structures within the brain

Research news

Severe type 2 asthma linked to subtle changes o...

Research presented at the recent European Respiratory Society Congress in Barcelona, Spain, sugge...

Test of AlphaFold 3 exposes limitations in amyloid structure prediction models

Research news

Test of AlphaFold 3 exposes limitations in amyl...

AI model generates amyloid-like structures for many non-amyloid controls underlining the need for...

ERC grant set to support neuroscience research into first-person perception

News

ERC grant set to support neuroscience research...

University of Bonn professor will receive approximately €1.5 million over five years to examine...

Bacteria produces testosterone from steroid precursor DHEA in the laboratory

Research news

Bacteria produces testosterone from steroid pre...

Scientists have identified a bacterium from the human urinary tract that can convert the steroid...

Diabetes, weight-loss drug semaglutide linked to fewer asthma exacerbations

News

Diabetes, weight-loss drug semaglutide linked t...

Research presented at the European Respiratory Society Congress in Barcelona, Spain, has found th...

Repurposed cancer drug could reverse bone loss, weight gain post-menopause

Research news

Repurposed cancer drug could reverse bone loss,...

Researchers at the University of East Anglia have found that CADD522, a compound originally devel...

Related Stories

News

Scottish Enterprise Life Sciences Awards

Scottish Enterprise Life Sciences Awards

News

Scottish Enterprise Life Sciences Awards 2014 – winners revealed

Scottish Enterprise Life Sciences Awa...

News

Special Recognition Award - Professor Chris Packard

Special Recognition Award - Professor...

News

Scotland's life sciences sector champions revealed

Scotland's life sciences sector champ...

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

View all digital editions

Explore Our Other Sites

Envirotech Online

DC Circuit ruling extends Superfund liability exposure to PFAS

Pollution Solutions Online

Safe drinking water worldwide

Petro Online

New dew point monitoring technology brings continuous measurement to hazardous location

Chromatography Today

Inline degasser range upgraded with new vacuum control and pump technology